Free Trial

Quanterix (QTRX) Expected to Announce Quarterly Earnings on Thursday

Quanterix logo with Medical background

Quanterix (NASDAQ:QTRX - Get Free Report) is expected to post its quarterly earnings results before the market opens on Thursday, March 6th. Analysts expect Quanterix to post earnings of ($0.27) per share and revenue of $34.93 million for the quarter.

Quanterix (NASDAQ:QTRX - Get Free Report) last released its earnings results on Monday, December 23rd. The company reported ($0.22) earnings per share for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. On average, analysts expect Quanterix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quanterix Stock Performance

Shares of Quanterix stock traded up $0.11 on Friday, reaching $7.59. 1,492,853 shares of the stock were exchanged, compared to its average volume of 836,530. The firm's 50 day moving average is $9.30 and its 200-day moving average is $11.41. The firm has a market cap of $292.40 million, a PE ratio of -7.16 and a beta of 1.33. Quanterix has a one year low of $7.30 and a one year high of $29.70.

Analysts Set New Price Targets

Separately, TD Cowen raised their target price on Quanterix from $13.50 to $16.00 and gave the company a "hold" rating in a report on Wednesday, November 13th.

View Our Latest Stock Analysis on QTRX

Quanterix Company Profile

(Get Free Report)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

Featured Articles

Earnings History for Quanterix (NASDAQ:QTRX)

Should You Invest $1,000 in Quanterix Right Now?

Before you consider Quanterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.

While Quanterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines